Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362601881> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W4362601881 abstract "For the reduction of PTH levels, two classes of drugs are available in the Brazilian market: non-selective and selective vitamin D receptor activators and calcimimetics. Among the mentioned drugs, the SUS provides oral calcitriol, paricalcitol and cinacalcet.Develop cost-effectiveness (CE) and budgetary impact (BI) analysis of cinacalcet versus paricalcitol for patients on dialysis with SHPT, from the perspective of SUS.A decision tree model was constructed for CE analysis, which considered the outcome of avoided parathyroidectomy and a time horizon of 1 year. As for the BI analysis, two scenarios were considered, one of which was measured demand and other epidemiological, based on data from the Brazilian Society of Nephrology (BSN).The CE analysis showed that the use of cinacalcet results in one-off savings of R$1,394.64 per year and an incremental effectiveness of 0.08, in relation to avoided parathyroidectomy. The incremental CE ratio (ICER) was - R$ 17,653.67 per avoided parathyroidectomy for cinacalcet, as it was more effective and cheaper compared to paricalcitol. As for the BI analysis, it was estimated that the incremental BI with the expansion of the use of cinacalcet in the SUS will be between - R$ 1,640,864.62 and R$ 166,368.50 in the first year, considering the main and the epidemiological scenarios. At the end of 5 years after the expansion of use, an BI was estimated between - R$ 10,740,743.86 and - R$ 1,191,339.37; considering the same scenarios.Cinacalcet was dominant to avoid parathyroidectomies, being cost-effective." @default.
- W4362601881 created "2023-04-06" @default.
- W4362601881 creator A5013330308 @default.
- W4362601881 creator A5042656619 @default.
- W4362601881 creator A5048212818 @default.
- W4362601881 creator A5061509861 @default.
- W4362601881 creator A5077395733 @default.
- W4362601881 creator A5079718233 @default.
- W4362601881 date "2023-04-03" @default.
- W4362601881 modified "2023-10-16" @default.
- W4362601881 title "Cost-effectiveness analysis of cinacalcet vs. paricalcitol in the treatment of hyperparathyroidism secondary to chronic kidney disease" @default.
- W4362601881 cites W1972007758 @default.
- W4362601881 cites W2122664355 @default.
- W4362601881 cites W3030959380 @default.
- W4362601881 cites W4211140718 @default.
- W4362601881 doi "https://doi.org/10.1590/2175-8239-jbn-2022-0126en" @default.
- W4362601881 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37015047" @default.
- W4362601881 hasPublicationYear "2023" @default.
- W4362601881 type Work @default.
- W4362601881 citedByCount "0" @default.
- W4362601881 crossrefType "journal-article" @default.
- W4362601881 hasAuthorship W4362601881A5013330308 @default.
- W4362601881 hasAuthorship W4362601881A5042656619 @default.
- W4362601881 hasAuthorship W4362601881A5048212818 @default.
- W4362601881 hasAuthorship W4362601881A5061509861 @default.
- W4362601881 hasAuthorship W4362601881A5077395733 @default.
- W4362601881 hasAuthorship W4362601881A5079718233 @default.
- W4362601881 hasBestOaLocation W43626018811 @default.
- W4362601881 hasConcept C126322002 @default.
- W4362601881 hasConcept C126894567 @default.
- W4362601881 hasConcept C2775945674 @default.
- W4362601881 hasConcept C2777645128 @default.
- W4362601881 hasConcept C2778653478 @default.
- W4362601881 hasConcept C2778838027 @default.
- W4362601881 hasConcept C2779524405 @default.
- W4362601881 hasConcept C2780534505 @default.
- W4362601881 hasConcept C2781208988 @default.
- W4362601881 hasConcept C519063684 @default.
- W4362601881 hasConcept C71924100 @default.
- W4362601881 hasConceptScore W4362601881C126322002 @default.
- W4362601881 hasConceptScore W4362601881C126894567 @default.
- W4362601881 hasConceptScore W4362601881C2775945674 @default.
- W4362601881 hasConceptScore W4362601881C2777645128 @default.
- W4362601881 hasConceptScore W4362601881C2778653478 @default.
- W4362601881 hasConceptScore W4362601881C2778838027 @default.
- W4362601881 hasConceptScore W4362601881C2779524405 @default.
- W4362601881 hasConceptScore W4362601881C2780534505 @default.
- W4362601881 hasConceptScore W4362601881C2781208988 @default.
- W4362601881 hasConceptScore W4362601881C519063684 @default.
- W4362601881 hasConceptScore W4362601881C71924100 @default.
- W4362601881 hasLocation W43626018811 @default.
- W4362601881 hasLocation W43626018812 @default.
- W4362601881 hasOpenAccess W4362601881 @default.
- W4362601881 hasPrimaryLocation W43626018811 @default.
- W4362601881 hasRelatedWork W1996609898 @default.
- W4362601881 hasRelatedWork W2007947358 @default.
- W4362601881 hasRelatedWork W2114197174 @default.
- W4362601881 hasRelatedWork W2136486000 @default.
- W4362601881 hasRelatedWork W2767174426 @default.
- W4362601881 hasRelatedWork W2884856032 @default.
- W4362601881 hasRelatedWork W4205424481 @default.
- W4362601881 hasRelatedWork W4312116887 @default.
- W4362601881 hasRelatedWork W4362601881 @default.
- W4362601881 hasRelatedWork W2743185259 @default.
- W4362601881 isParatext "false" @default.
- W4362601881 isRetracted "false" @default.
- W4362601881 workType "article" @default.